Tasly Pharmaceutical Group Co., Ltd 600535.SS Stock
Tasly Pharmaceutical Group Co., Ltd Price Chart
Tasly Pharmaceutical Group Co., Ltd 600535.SS Financial and Trading Overview
| Tasly Pharmaceutical Group Co., Ltd stock price | 15.74 CNY |
| Previous Close | 14.57 CNY |
| Open | 14.59 CNY |
| Bid | 14.59 CNY x N/A |
| Ask | 14.6 CNY x N/A |
| Day's Range | 14.56 - 14.91 CNY |
| 52 Week Range | 9.2 - 17.14 CNY |
| Volume | 7.64M CNY |
| Avg. Volume | 17.63M CNY |
| Market Cap | 21.9B CNY |
| Beta (5Y Monthly) | 0.406506 |
| PE Ratio (TTM) | 38.421055 |
| EPS (TTM) | 0.75 CNY |
| Forward Dividend & Yield | 0.33 (2.27%) |
| Ex-Dividend Date | May 22, 2023 |
| 1y Target Est | 12.1 CNY |
600535.SS Valuation Measures
| Enterprise Value | 20.92B CNY |
| Trailing P/E | 38.421055 |
| Forward P/E | 18.481012 |
| PEG Ratio (5 yr expected) | -1.31 |
| Price/Sales (ttm) | 2.4886887 |
| Price/Book (mrq) | 1.7366482 |
| Enterprise Value/Revenue | 2.378 |
| Enterprise Value/EBITDA | 11.697 |
Trading Information
Tasly Pharmaceutical Group Co., Ltd Stock Price History
| Beta (5Y Monthly) | 0.406506 |
| 52-Week Change | 37.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 17.14 CNY |
| 52 Week Low | 9.2 CNY |
| 50-Day Moving Average | 15.28 CNY |
| 200-Day Moving Average | 12.56 CNY |
600535.SS Share Statistics
| Avg. Volume (3 month) | 17.63M CNY |
| Avg. Daily Volume (10-Days) | 12.57M CNY |
| Shares Outstanding | 1.5B |
| Float | 767.88M |
| Short Ratio | N/A |
| % Held by Insiders | 49.99% |
| % Held by Institutions | 4.09% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.33 |
| Trailing Annual Dividend Yield | 2.26% |
| 5 Year Average Dividend Yield | 215.00% |
| Payout Ratio | 0.87 |
| Last Split Factor | 1.4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 6.44% |
| Operating Margin (ttm) | 15.49% |
| Gross Margin | 64.47% |
| EBITDA Margin | 20.32% |
Management Effectiveness
| Return on Assets (ttm) | 4.99% |
| Return on Equity (ttm) | 4.05% |
Income Statement
| Revenue (ttm) | 8.8B CNY |
| Revenue Per Share (ttm) | 5.88 CNY |
| Quarterly Revenue Growth (yoy) | 10.90% |
| Gross Profit (ttm) | 5.48B CNY |
| EBITDA | 1.79B CNY |
| Net Income Avi to Common (ttm) | 567.24M CNY |
| Diluted EPS (ttm) | 0.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.46B CNY |
| Total Cash Per Share (mrq) | 2.98 CNY |
| Total Debt (mrq) | 3.38B CNY |
| Total Debt/Equity (mrq) | 26.35 CNY |
| Current Ratio (mrq) | 3.454 |
| Book Value Per Share (mrq) | 8.407 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.35B CNY |
| Levered Free Cash Flow (ttm) | 1.01B CNY |
Profile of Tasly Pharmaceutical Group Co., Ltd
| Country | China |
| State | N/A |
| City | Tianjin |
| Address | No. 2, Puji East Road |
| ZIP | 300410 |
| Phone | 86 22 2673 6999 |
| Website | https://www.taslypharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 9183 |
Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China.
Q&A For Tasly Pharmaceutical Group Co., Ltd Stock
What is a current 600535.SS stock price?
Tasly Pharmaceutical Group Co., Ltd 600535.SS stock price today per share is 15.74 CNY.
How to purchase Tasly Pharmaceutical Group Co., Ltd stock?
You can buy 600535.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tasly Pharmaceutical Group Co., Ltd?
The stock symbol or ticker of Tasly Pharmaceutical Group Co., Ltd is 600535.SS.
Which industry does the Tasly Pharmaceutical Group Co., Ltd company belong to?
The Tasly Pharmaceutical Group Co., Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Tasly Pharmaceutical Group Co., Ltd have in circulation?
The max supply of Tasly Pharmaceutical Group Co., Ltd shares is 1.49B.
What is Tasly Pharmaceutical Group Co., Ltd Price to Earnings Ratio (PE Ratio)?
Tasly Pharmaceutical Group Co., Ltd PE Ratio is 20.98666600 now.
What was Tasly Pharmaceutical Group Co., Ltd earnings per share over the trailing 12 months (TTM)?
Tasly Pharmaceutical Group Co., Ltd EPS is 0.75 CNY over the trailing 12 months.
Which sector does the Tasly Pharmaceutical Group Co., Ltd company belong to?
The Tasly Pharmaceutical Group Co., Ltd sector is Healthcare.